Literature DB >> 27911673

Genetic Syndromes Associated with Central Nervous System Tumors.

Charmi Vijapura1, Ehab Saad Aldin1, Aristides A Capizzano1, Bruno Policeni1, Yutaka Sato1, Toshio Moritani1.   

Abstract

Several genetic tumor syndromes have associated central nervous system (CNS) neoplasms. The spectrum of syndromes that have intracranial tumor manifestations includes ataxia telangiectasia, Cowden syndrome, familial adenomatous polyposis, hereditary non-polyposis-related colorectal cancer, Li-Fraumeni syndrome, Gorlin syndrome, neurofibromatosis types 1 and 2, multiple endocrine neoplasia type 1, tuberous sclerosis complex, von Hippel-Lindau disease, and Turcot syndrome. Many of these disorders are inherited in an autosomal dominant fashion, and identification of the associated genetic defects has led to improved understanding of the molecular pathways involved in tumorigenesis, helping pave the way to the emergence of molecularly targeted therapeutics. Recognition of individuals and families at risk for such tumors is critical to improve clinical care and optimize proper genetic counseling. To contribute effectively, the radiologist should recognize the common varieties of tumors and characteristic neuroimaging manifestations seen in each familial syndrome. A fundamental understanding of the genetics and molecular pathogenesis of these tumors is critical in understanding the development of specific and unique tumors in each entity. In this article, we review the most common genetic tumor syndromes with associated intracranial neoplasms, with emphasis on recent genetic and molecular biology data, clinical manifestations, and management as well as the controversies and current recommendations for screening and surveillance. A detailed overview of all the major and pertinent CNS imaging features will be elucidated, including computed tomography, magnetic resonance imaging, and, in relevant cases, magnetic resonance spectroscopy. ©RSNA, 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27911673     DOI: 10.1148/rg.2017160057

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  7 in total

Review 1.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

Review 2.  Vesiclemia: counting on extracellular vesicles for glioblastoma patients.

Authors:  Quentin Sabbagh; Gwennan Andre-Gregoire; Laetitia Guevel; Julie Gavard
Journal:  Oncogene       Date:  2020-08-14       Impact factor: 9.867

Review 3.  Risk factors for childhood and adult primary brain tumors.

Authors:  Quinn T Ostrom; Maral Adel Fahmideh; David J Cote; Ivo S Muskens; Jeremy M Schraw; Michael E Scheurer; Melissa L Bondy
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

Review 4.  Could dietary erucic acid lower risk of brain tumors? An epidemiological look to Chinese population with implications for prevention and treatment.

Authors:  Meric A Altinoz
Journal:  Metab Brain Dis       Date:  2022-06-15       Impact factor: 3.584

Review 5.  Updates in IDH-Wildtype Glioblastoma.

Authors:  Mary Jane Lim-Fat; James R Perry; Jawad M Melhem; Jay Detsky
Journal:  Neurotherapeutics       Date:  2022-05-31       Impact factor: 6.088

6.  Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan.

Authors:  Kuo-Sheng Wu; Donald Ming-Tak Ho; Shiann-Tarng Jou; Alice L Yu; Huy Minh Tran; Muh-Lii Liang; Hsin-Hung Chen; Yi-Yen Lee; Yi-Wei Chen; Shih-Chieh Lin; Feng-Chi Chang; Min-Lan Tsai; Yen-Lin Liu; Hsin-Lun Lee; Kevin Li-Chun Hsieh; Wen-Chang Huang; Shian-Ying Sung; Che-Chang Chang; Chun Austin Changou; Kung-Hao Liang; Tsung-Han Hsieh; Yun-Ru Liu; Meng-En Chao; Wan Chen; Shing-Shung Chu; Er-Chieh Cho; Tai-Tong Wong
Journal:  Cancers (Basel)       Date:  2020-03-11       Impact factor: 6.639

7.  Clear-cell renal cell carcinoma and glioblastoma multiforme coexistence: Double primary malignancy, does it have a causal relationship?

Authors:  Kevin Ariel Tiopan Simanjuntak; Asra Al Fauzi; Ayu Yoniko Christi; Perthdyatama Syifaq Budiono; Rahadian Indarto Susilo; Irwan Barlian Immadoel Haq; Nur Setiawan Suroto; Dyah Fauziah; Wahjoe Djatisoesanto
Journal:  Surg Neurol Int       Date:  2022-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.